Skip to main content
SOLARA ACTIVE PHARMA SCIENCES LIMITED logo

SOLARA ACTIVE PHARMA SCIENCES LIMITED — Investor Relations & Filings

Ticker · SOLARA ISIN · INE624Z01016 LEI · 3358008SUKH3YE2F7F81 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2026-05-15 Report Publication Anno…
Country IN India
Listing BSE.NS SOLARA

About SOLARA ACTIVE PHARMA SCIENCES LIMITED

https://www.solara.co.in/

Solara Active Pharma Sciences Limited is a customer-centric organization specializing in the development and manufacturing of active pharmaceutical ingredients (APIs). The company offers a diverse portfolio of high-quality products across therapeutic categories such as pain management, central nervous system, and anti-infectives. It operates several manufacturing sites and research centers that comply with global regulatory standards, including the USFDA and EUGMP. Beyond its commercial API catalog, the company provides comprehensive contract development and manufacturing organization (CDMO) services, assisting partners from the initial research phase to large-scale production. Known for its significant production capacity in key molecules like Ibuprofen, the company focuses on delivering complex and niche APIs to global markets through advanced technical expertise and a commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 87% confidence The document is a brief notice to stock exchanges that the audio recording of the Q4 FY26 earnings call has been uploaded to the company’s website, without containing any actual financial data or transcript. It announces the publication of a report (the call audio) rather than providing the report itself, fitting the definition of a Report Publication Announcement (RPA).
2026-05-15 English
Solara Active Pharma Sciences Limited has intimated the Exchange about the Audio Recording of the Q4 FY26 Earnings Call held on May 15, 2026, at 15.00 IST.
Report Publication Announcement Classification · 85% confidence The document is a short notification to stock exchanges under SEBI regulations stating that the audio recording of the Q4 FY26 earnings call has been uploaded to the company website. It does not include any financial data or the transcript itself, but merely announces the availability of the audio report. This fits the definition of a Report Publication Announcement (RPA).
2026-05-15 English
Monitoring Agency Report for the quarter ended March 31, 2026
Regulatory Filings Classification · 90% confidence The document is a statutory compliance filing under SEBI (LODR) Reg. 32(6) and SEBI ICDR Reg. 82(4), providing the full Monitoring Agency Report on utilization of proceeds from a Rights Issue for the quarter ended 31 Mar 2026. It is neither a full financial report (10-K/IR), nor a simple earnings release or management presentation. It is a regulatory compliance report sent to the exchanges, falling under “General regulatory announcements / compliance documents” – i.e., the RNS category.
2026-05-15 English
Monitoring Agency Report
Regulatory Filings Classification · 85% confidence The document is a Monitoring Agency Report issued by Crisil Ratings Limited for the quarter ended March 31, 2026, pursuant to SEBI Listing Obligations and SEBI ICDR Regulations concerning a Rights Issue. It contains detailed tables on utilisation of proceeds and confirmations, but it is neither an earnings release, annual/interim report, nor an audit report. There is no bespoke category for monitoring agency reports, so it falls under the catch-all Regulatory Filings (RNS) category.
2026-05-15 English
Solara Active Pharma Sciences Limited has informed the exchange regarding the approval and adoption of the Board Evaluation Policy and amendment to Whistle Blower Policy
Regulatory Filings Classification · 84% confidence The document is an intimation under SEBI Listing Regulations to the stock exchanges, detailing board approval of policy revisions (Board Evaluation Policy and Whistle Blower Policy). It is a regulatory disclosure rather than an actual financial report, management change, or governance report. It does not contain financial statements or constitute an AGM/EGM report; it is a routine regulatory filing under continuous disclosure obligations, making it best classified as a general regulatory announcement (RNS).
2026-05-15 English
General Updates
Governance Information Classification · 82% confidence The document is an Exchange filing under SEBI LODR Regulation 30, notifying revisions to the company’s internal governance policies (Board Evaluation Policy and Whistle Blower Policy) approved by the Board of Directors. It does not announce management changes, dividends, or results, but relates specifically to governance policies. This fits the definition of Governance Information (CGR).
2026-05-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.